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Lead and cadmium are ubiquitous environ-
mental toxicants that are related to a broad
range of physiologic, biochemical, and behav-
ioral dysfunctions (Goyer 1990; Satarug and
Moore 2004). Lead and cadmium potentially
induce oxidative stress; evidence is accumulat-
ing to support the role of oxidative stress in
the pathophysiology of lead or cadmium poi-
soning (Ercal et al. 2001; Stohs and Bagchi
1995). Until now, evidence on lead- or
cadmium-induced oxidative stress has been
based mostly on in vitro experiments (Ding
et al. 2000; Gaubin et al. 2000; Kim et al.
2005; Loikkanen et al. 1998) or animal stud-
ies (Cabell et al. 2004; Farmand et al. 2005;
Fowler et al. 2004; Tandon et al. 2003).
Several epidemiologic studies among workers
with high occupational exposure to lead have
reported associations between lead exposure
and oxidative stress markers (Costa et al.
1997; Gurer-Orhan et al. 2004; Kasperczyk
et al. 2004).
Concern about environmental exposure to
lead or cadmium as a signiﬁcant public health
problem has increased as epidemiologic and
experimental evidence has mounted regarding
adverse health effects at successively lower lev-
els of lead or cadmium exposure (Davis et al.
1993; Satarug et al. 2003). Recent epidemio-
logic studies have reported that environmental
exposure to lead or cadmium concentration
has a graded association with several disease
outcomes such as hypertension, peripheral
artery diseases, kidney diseases, and cognitive
impairment (Elliott et al. 2000; Jarup et al.
1998; Koller et al. 2004; Muntner et al. 2003;
Nash et al. 2003; Navas-Acien et al. 2004).
Although all these diseases include com-
ponents of oxidative stress (Hogg 1998), the
relevance of oxidative stress to lead- and
cadmium-related diseases in the general popu-
lation with low environmental exposure has
been criticized because mechanistic studies are
typically conducted at higher doses than the
concentrations observed in general population
(Navas-Acien et al. 2004).
To explore the possibility that oxidative
stress may be involved in the pathogenesis of
lead- or cadmium-related diseases in the general
population, we examined the cross-sectional
associations of blood lead and urinary
cadmium levels with serum γ-glutamyltrans-
ferase (GGT), vitamin C, carotenoids, and
vitamin E in a representative sample of the
U.S. population using the Third National
Health and Nutrition Examination Survey
(NHANES III). We expected a positive asso-
ciation of blood lead or urinary cadmium lev-
els with serum GGT and inverse associations
with vitamin C, carotenoids, and vitamin E.
Although an abnormal level of serum GGT, a
well-known enzyme, is a marker of liver
dysfunction or alcohol consumption, serum
GGT within its normal range has been
recently proposed as an early and sensitive
biomarker of oxidative stress (Lee et al.
2004). Finding a threshold above which
blood lead and cadmium are associated with
oxidative stress in the general population
could be helpful in setting safety levels for
environmental exposure to these metals.
Materials and Methods
NHANES III is a national examination study
conducted in the United States from 1988
through 1994 by the National Center for
Health Statistics of the Centers for Disease
Control and Prevention (CDC). It used com-
plex, multistage, stratiﬁed, clustered samples
of civilian, noninstitutionalized populations
2 months of age and older. A detailed descrip-
tion of survey methods and data collection
procedures has been published elsewhere
(National Center for Health Statistics 1996).
Study sample. Of 18,825 sampled persons
≥ 20 years of age, 16,573 (88%) attended an
examination at a mobile examination center.
Pregnant women (n = 288) and participants
with missing data on serum lead, GGT, vita-
min C, carotenoids, vitamin E, or urinary cad-
mium or creatinine concentrations (n = 5,310)
were excluded. We additionally excluded those
with missing data on confounders (n = 1,679).
Finally, 10,098 study participants remained
for analysis.
Measurements. The NHANES III data
collection included a standardized home
interview followed by a detailed physical
examination in a mobile examination center
or the participant’s home. Information on a
wide variety of sociodemographic, medical
history, nutritional history, and family history
Address correspondence to D.-H. Lee, Department of
Preventive Medicine, School of Medicine, Kyungpook
University, 101 Dongin-dong, Jung-gu, Daegu, Korea
700-422. Telephone: 82-53-420-6960. Fax: 82-53-
425-2447. E-mail: lee_dh@knu.ac.kr
This study was partly supported in Korea by
Kyungpook National University Research Fund
(2003), and the Korea Health 21 R&D Project,
Ministry of Health and Welfare, Republic of Korea
(A050349); in the United States by a grant from the
National Heart, Lung, and Blood Institute (R01 H1
53560) (Young Adults Longitudinal Trends in
Antioxidants).
The authors declare they have no competing
ﬁnancial interests.
Received 21 July 2005; accepted 15 November 2005.
Graded Associations of Blood Lead and Urinary Cadmium Concentrations
with Oxidative-Stress–Related Markers in the U.S. Population: Results from
the Third National Health and Nutrition Examination Survey
Duk-Hee Lee,1 Ji-Sun Lim,1 Kyungeun Song,2 Yongchool Boo,3 and David R. Jacobs Jr.4,5
1Department of Preventive Medicine and Health Promotion Research Center, 2Department of Clinical Pathology, School of Medicine, and
3Department of Molecular Biology, School of Medicine, Kyungpook National University, Daegu, South Korea; 4Division of Epidemiology,
School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA; 5Department of Nutrition, University of Oslo, Oslo,
Norway
Although oxidative stress has been proposed as a mechanism of lead and cadmium toxicity mostly
based on in vitro experiments or animal studies, it is uncertain whether this mechanism is relevant in
the pathogenesis of lead- or cadmium-related diseases in the general population with low environ-
mental exposure to lead and cadmium. We examined associations of blood lead and urinary cad-
mium levels with oxidative stress markers of serum γ-glutamyltransferase (GGT), vitamin C,
carotenoids, and vitamin E among 10,098 adult participants in the third U.S. National Health and
Nutrition Examination Survey. After adjusting for race, sex, and age (plus serum total cholesterol in
the case of serum carotenoids and vitamin E), blood lead and urinary cadmium levels both showed
graded associations, positive with serum GGT and inverse with serum vitamin C, carotenoids, and
vitamin E (p for trend < 0.01, respectively). These associations were consistently observed among
most subgroups: non-Hispanic white, non-Hispanic black, men, women, all age groups, non-
drinkers, drinkers, nonsmokers, ex-smokers, current smokers, and body mass index (< 25, 25–29.9,
and ≥ 30). The strong association of blood lead and urinary cadmium levels with oxidative stress
markers in this population suggests that oxidative stress should be considered in the pathogenesis of
lead- and cadmium-related diseases even among people with low environmental exposure to lead and
cadmium. Key words: cadmium, carotenoid, γ-glutamyltransferase, lead, oxidative stress, vitamin C,
vitamin E. Environ Health Perspect 114:350–354 (2006). doi:10.1289/ehp.8518 available via
http://dx.doi.org/ [Online 15 November 2005]questions, such as self-reported age, race/
ethnicity, sex, history of smoking, alcohol
consumption, use of vitamin supplements,
and 24-hr dietary recall, were obtained during
the home interview.
Venous blood and urine samples were
collected and shipped weekly at –20°C.
Blood lead levels and urinary cadmium were
determined using graphite furnace atomic
absorption spectrophotometry. Serum GGT
concentration was assayed with a Hitachi 737
Analyzer (Boehringer-Mannheim Diagnostics,
Indianapolis, IN, USA) at White Sands
Research Center, Alamogordo, New Mexico
(USA). Serum extract was prepared in the
vial for vitamin C analysis by diluting 500 µL
serum with 2.0 mL freshly prepared 6 mg/dL
metaphosphoric acid diluent and thoroughly
mixing the resulting solution of clear liquid
and white precipitated proteins. Serum vitamin
C was measured by isocratic high-performance
liquid chromatography (HPLC) with electro-
chemical detection at 650 mV. Serum
carotenoids (α-carotene, β-carotene, β-crypto-
xanthin, lutein/zeaxanthin, and lycopene) and
vitamin E concentrations were measured by
isocratic HPLC with detection at 300, 325,
and 450 nm using a Waters HPLC system
(Waters Chromatography Division of Millipore
Corporation, Marlboro, MA, USA) at the
NHANES Laboratory. Serum total cholesterol
was measured using a Hitachi 704 Analyzer
(Boehringer-Mannheim Diagnostics) at the
Johns Hopkins University Hospital Lipo-
protein Analytical Laboratory (Baltimore, MD,
USA) and White Sands Research Center.
Statistical analysis. We classified both
blood lead and urinary cadmium levels into
deciles: Cutoff points of blood lead deciles
were 1.0, 1.5, 1.9, 2.4, 2.9, 3.5, 4.2, 5.2, and
7.1 µg/dL and those of urinary cadmium were
0.11, 0.18, 0.25, 0.33, 0.41, 0.52, 0.67, 0.88,
and 1.24 µg/g creatinine. Serum GGT and
some serum antioxidant vitamin levels were
right-skewed, so results are presented as
geometric means across deciles of blood lead
or urinary cadmium levels. We also present
the associations of serum alanine aminotrans-
ferase (ALT), a liver-specific enzyme, with
blood lead and urinary cadmium levels to
compare with those of GGT. We adjusted for
potential confounding by linear regression. In
this study, the internal validity was a more
important issue than was generalization to the
total U.S. population; therefore, we did not
use a specific analytic method to take into
account the sampling frame of NHANES III.
When we repeated the analyses considering
the sampling frame, the results of weighted
results were similar to those of unweighted
results. Adjusting variables were race/ethnicity,
sex, age (years), education (years), and poverty
income ratio. The values of carotenoids and
vitamin E were additionally adjusted for cho-
lesterol concentrations because the distribu-
tion of these lipophilic compounds across
various fat depots in the body is inﬂuenced by
circulating lipoprotein concentrations. In fully
adjusted models, we additionally adjusted for
body mass index (BMI; kilograms per square
meter), smoking status (nonsmoker, ex-
smoker, and current smoker), smoking
amount (packs), and alcohol intake (grams per
day). We repeated the same analyses after
stratifying by race (non-Hispanic white, non-
Hispanic black, others), sex (men, women),
alcohol consumption status (nondrinker,
drinker), smoking status (never smoker, ex-
smoker, current smoker), or BMI (< 25,
25–29.9, ≥ 30 kg/m2).
Results
Geometric means of blood lead and urinary
cadmium among the study subjects were
2.8 mg/dL and 0.37 µg/g creatinine, respec-
tively. The correlation of blood lead and uri-
nary cadmium was r = 0.24. After adjusting
for race, sex, age, education, and poverty
income ratio (plus serum total cholesterol in
the case of serum carotenoids and vitamin E),
in general, both blood lead and urinary cad-
mium levels were positively associated with
serum GGT, whereas they were inversely
associated with serum vitamin C, carotenoids,
and vitamin E (p for trend < 0.01, respec-
tively) (Table 1, Figure 1). These associations
were observed across most deciles of blood
lead and urinary cadmium. A partial excep-
tion was serum carotenoids and lead, where
the association was flat across deciles 1–5;
alternatively, a monotonic decrease started at
decile 5. When we separately analyzed five
carotenoids (α-carotene, β-carotene, β-crypto-
xanthin, lutein/zeaxanthin, lycopene), all
carotenoids except lutein/zeaxanthin (no asso-
ciation with lead) showed similar trends (data
not shown). In contrast, serum ALT, a liver-
speciﬁc enzyme, was not positively associated
with blood lead irrespective of adjustment for
serum GGT or with urinary cadmium after
adjustment for serum GGT. The positive
associations of both blood lead and urinary
cadmium with serum GGT were not changed
even after adjustment for serum ALT. All
these associations were not materially differ-
ent after additional adjustment for cigarette
smoking, alcohol intake, and BMI (data not
shown). Additional adjustments for dietary
intakes of vitamin C, carotenoids, and vita-
min E and supplement intake did not sub-
stantially change the results (data not shown).
We checked the interactions between blood
lead and urinary cadmium on the levels of
oxidative stress markers; however, there was
no reportable result (data not shown).
When we stratified the associations of
blood lead and urinary cadmium levels by
serum GGT or vitamin C by race, sex, age,
smoking status, drinking status, or BMI, the
positive or inverse associations of each with
serum GGT levels and vitamin C were similarly
observed among most subgroups: non-Hispanic
white, non-Hispanic black, men, women, all
age groups, nondrinkers, drinkers, nonsmokers,
ex-smokers, current smokers, BMI < 25, BMI
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Table 1. Adjusteda geometric means of serum GGT, vitamin C, carotenoids, and vitamin E by deciles of blood lead or urinary cadmium levels.
Decile p-Value
D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 β-Coefﬁcientb for trend
Blood lead levels (µg/dL) 0.7–1.0 1.1–1.5 1.6–1.9 2.0–2.4 2.5–2.9 3.0–3.5 3.6–4.2 4.3–5.2 5.3–7.1 7.2–56
GGT (U/L) 21.9 23.2 23.6 24.1 23.8 24.3 24.2 25.4 25.8 27.6 0.057 < 0.01
ALT (U/L) 14.5 14.9 15.7 15.5 15.4 14.8 14.9 14.8 14.3 13.9 –0.025 < 0.01
Vitamin C (mg/dL) 0.70 0.66 0.64 0.61 0.61 0.59 0.58 0.50 0.47 0.37 –0.175 < 0.01
Carotenoids (µg/dL)c 75 76 79 77 77 75 73 72 71 67 –0.040 < 0.01
Vitamin E (µg/dL) 1,110 1,096 1,100 1,101 1,087 1,062 1,077 1,057 1,035 974 –0.035 < 0.01
Urinary cadmium levels 0.002–0.11 0.12–0.18 0.19–0.25 0.26–0.33 0.34–0.41 0.42–0.52 0.53–0.67 0.68–0.88 0.89–1.24 1.25–23.4
(µg/g creatinine)
GGT (U/L) 20.9 21.0 23.0 23.3 24.2 25.1 25.3 26.4 27.1 28.4 0.053 < 0.01
ALT (U/L) 14.0 14.1 14.9 14.5 15.0 15.0 15.2 15.2 15.4 15.3 0.021 < 0.01
Vitamin C (mg/dL) 0.78 0.74 0.66 0.60 0.59 0.54 0.51 0.47 0.46 0.40 –0.125 < 0.01
Carotenoids (µg/dL)c 84 83 79 79 76 73 72 70 67 62 –0.058 < 0.01
Vitamin E (µg/dL) 1,126 1,109 1,094 1,071 1,072 1,071 1,048 1,037 1,053 1,019 –0.013 < 0.01
aAdjusted for race, sex, age, education, and poverty income ratio; concentrations of carotenoids and vitamin E were additionally adjusted for serum cholesterol. bβ-Coefficients:
adjusted slopes of the independent variable blood lead or urinary cadmium level (per SD). cSerum carotenoids were the sum of α-carotene, β-carotene, β-cryptoxanthin,
zeaxanthin/lutein, and lycopene.25–29.9, and BMI ≥ 30 kg/m2 (Tables 2 and
3). Some p-values for interactions were signiﬁ-
cant, but all β-coefficients were in the same
direction, and there was no clear pattern of
which subgroups had shallower or steeper
slopes. Results of stratiﬁed analyses of serum
carotenoids or vitamin E were similar to those
of vitamin C (data not shown).
Discussion
In this sample of the U.S. population, we doc-
umented that blood lead and urinary cadmium
levels across all deciles were positively associ-
ated with serum GGT levels, whereas they
were inversely associated with serum vitamin
C, carotenoids, and vitamin E. These associa-
tions were consistently demonstrated in all
subgroups. Importantly, the observed increase
of serum GGT and decrease of serum vitamin
C, carotenoids, and vitamin E occurred at lead
or cadmium levels much lower than current
safety levels used by environmental and occu-
pational regulatory agencies. For instance, only
three study participants had lead levels
> 40 µg/dL, the Occupational Safety and
Health Administration (OSHA) safety standard
for lead in whole blood (OSHA 2003), and
only 449 (4.1%) had lead levels > 10 µg/dL,
the CDC criterion for elevated blood levels in
children and pregnant women (CDC 2002).
Similarly, only 22 (0.2%) had urinary cad-
mium levels > 5 µg/g creatinine, the World
Health Organization (WHO) standard for uri-
nary cadmium (WHO 1999).
Lead or cadmium causes oxidative stress
by inducing the generation of reactive oxygen
species, reducing the antioxidant defense sys-
tems of cells via depleting glutathione, inhibit-
ing sulfhydryl-dependent enzymes, interfering
with some essential metals needed for anti-
oxidant enzyme activities, and/or increasing
susceptibility of cells to oxidative attack by
altering the membrane integrity and fatty acid
composition (Cabell et al. 2004; Ding et al.
2000; Farmand et al. 2005; Fowler et al.
2004; Gaubin et al. 2000; Kim et al. 2005;
Loikkanen et al. 1998; Tandon et al. 2003).
Consequently, it is plausible that impaired
oxidant/antioxidant balance can be partially
responsible for the toxic effects of lead or cad-
mium. Several epidemiologic studies among
workers with high occupational exposure
to lead have reported positive associations
between blood lead levels and oxidative stress
markers (Costa et al. 1997; Gurer-Orhan et al.
2004; Kasperczyk et al. 2004).
Despite the biologic plausibility, the rele-
vance of these mechanisms to the general pop-
ulation with low environmental exposure to
lead or cadmium has been criticized because
mechanistic studies are typically conducted at
higher doses than the concentrations observed
in the present study (Navas-Acien et al. 2004).
However, the present study strongly suggests
that oxidative stress is occurring even at low
levels of exposure to lead and cadmium.
Consequently, it should be considered as a rel-
evant mechanism in the pathophysiology of
lead- or cadmium-related diseases, even in
those with low environmental exposure to lead
or cadmium.
The general population can be exposed to
lead in ambient air near industrial and com-
bustion sources, in certain foods, through
Lee et al.
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Table 2. Adjusteda slopes of blood lead level (per SD of lead) on serum GGT and vitamin C, stratified by
race, sex, age, smoking status, drinking status, or BMI.
GGT Vitamin C
Sample (n) β-Coefﬁcient p-Value for trend β-Coefﬁcient p-Value for trend
Race
Non-Hispanic white 4,485 0.031 0.01 –0.183 < 0.01
Non-Hispanic black 2,820 0.078 < 0.01 –0.185 < 0.01
Others 2,793 0.010 0.53 –0.083 < 0.01
p-Value for interaction 0.88 < 0.01
Sex
Men 4,799 0.063 < 0.01 –0.167 < 0.01
Women 5,299 0.049 < 0.01 –0.196 < 0.01
p-Value for interaction 0.04 0.76
Age (years)
20–39 4,178 0.052 < 0.01 –0.128 < 0.01
40–59 2,831 0.068 < 0.01 –0.217 < 0.01
≥ 60 3,089 0.023 0.03 –0.165 < 0.01
p-Value for interaction < 0.01 0.01
Smoking
Never 5,016 0.028 0.03 –0.075 < 0.01
Ex 2,550 0.043 < 0.01 –0.161 < 0.01
Current 2,532 0.063 < 0.01 –0.150 < 0.01
p-Value for interaction 0.51 < 0.01
Drinking
No 7,707 0.021 0.02 –0.159 < 0.01
Yes 2,391 0.105 < 0.01 –0.198 < 0.01
p-Value for interaction < 0.01 0.02
BMI
< 25 3,900 0.093 < 0.01 –0.211 < 0.01
25–29.9 3,567 0.052 < 0.01 –0.141 < 0.01
≥ 30 2,631 0.034 0.04 –0.172 < 0.01
p-Value for interaction < 0.01 < 0.01
aAdjusted for race, sex, age, education, and poverty income ratio.
Figure 1. Geometric means of serum GGT (A), vitamin C (B), carotenoids (C), and vitamin E (D) by deciles of
blood lead or urinary cadmium levels, adjusted for race, sex, age, education, and poverty income ratio.
Concentrations of carotenoids and vitamin E were additionally adjusted for serum cholesterol. Serum
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C Dsmoking, and sometimes in drinking water
[Agency for Toxic Substances and Disease
Registry (ATSDR) 1999b]. Lead exposure has
declined substantially in the last two decades
since the ban on leaded gasoline (Pirkle et al.
1994). Since NHANES II, the blood lead con-
centrations declined dramatically in the U.S.
population (Pirkle et al. 1994). For example,
among the U.S. population 1–74 years of age,
mean blood lead concentrations dropped by
78% from 12.8 µg/dL during NHANES II
(1976–1980) to 2.8 µg/dL during the first
phase of NHANES III (1988–1991). Exposure
to cadmium in the general population results
from exposure to cigarette smoke, inhalation of
ambient air near coal-ﬁred power plants and
municipal waste incinerators, and consump-
tion of some foods (highest levels in shellﬁsh,
liver, and kidney meats) (ATSDR 1999a).
Serum GGT levels within normal range
has been recently proposed as an early and
sensitive marker of oxidative stress based on
both experimental and epidemiologic studies
(Lee et al. 2004). Even though serum GGT
was highly correlated with serum ALT in these
data (correlation = 0.54), the associations of
serum ALT within its normal range with
serum antioxidant vitamin levels or C-reactive
protein were very different from those of
GGT within its normal range. For example,
serum GGT was clearly and inversely associ-
ated with serum antioxidant vitamins, whereas
serum ALT was not associated or sometimes
positively associated with them (Lim et al.
2004). In addition, serum GGT was clearly
and positively associated with serum C-reactive
protein, whereas serum ALT was not positively,
if anything inversely, associated with serum
C-reactive protein (Lee and Jacobs 2005).
Thus, we assert that serum GGT within nor-
mal range, different from serum ALT, may be a
marker related to oxidative stress.
The strengths of our study include the rig-
orous methodology and extensive quality con-
trol of NHANES procedures, the use of a
nationally representative sample, and the con-
sistent ﬁndings in most subgroups. Our ﬁnd-
ings, however, must be interpreted in the
context of certain limitations. First, serum
GGT and antioxidant vitamins as oxidative-
stress–related markers were selected based on
availability in NHANES III. In fact, there are
various biologic markers that are used to assess
oxidative stress that include F2 isoprostanes,
8-hydroxydeoxyguanosine, and protein car-
bonyls (Mayne 2003). These biomarkers give a
view of oxidative damage to, respectively, lipid,
DNA, and protein but individually do not give
a global view of whole-body stress (Mayne
2003). At present, it is unclear which oxida-
tive-stress–related biomarker may be most rele-
vant in oxidative stress induced by lead or
cadmium. Second, even though we focused on
lead and cadmium in this study, there may be
concomitant exposure to other metals that can
also induce oxidative stress. However, such
coexposure may be more common for workers
exposed to high levels of lead or cadmium in
occupational settings than to exposure in the
general population. Third, our analyses were
based on single blood or urine measurements
of lead and cadmium, which are imperfect bio-
markers of chronic exposure. Environmental
exposures, however, are likely to be less
changeable than occupational exposures, and
single blood or urine levels are frequently used
as biomarkers in population studies. Finally,
NHANES used spot urine to measure urinary
cadmium, not 24-hr urine collection. Even
though we adjusted for urinary creatinine to
account for urine dilution, the adequacy of
correcting for creatinine has been questioned
(Ikeda et al. 2003). In our data, the ﬁndings
using models with and without adjustment for
creatinine were similar and do not affect the
conclusions.
In conclusion, this study ﬁnds evidence of
oxidative stress at levels of blood lead and uri-
nary cadmium substantially lower than those
labeled as dangerous by OSHA, CDC, or
WHO. At present, it is unclear whether slight
increases of oxidative stress markers or slight
decreases of serum antioxidants increase the
future risk of clinical outcomes; nevertheless,
this increased oxidative stress might be harm-
ful. Even though it needs conﬁrmation in fur-
ther studies, our present study suggests that
the consumption of antioxidant-rich foods
such as fruits or vegetables may be helpful
to prevent harmful effects of environmental
lead or cadmium exposures. These findings
should be borne in mind in thinking about
possible adverse effects of lead or cadmium
and in setting alert levels for blood lead or
cadmium.
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